Thalassaemia

NEW WEBINAR | Exploring The Value Of Patient Advocacy For Better Thalassaemia Care
أخبار

NEW WEBINAR | Exploring The Value Of Patient Advocacy For Better Thalassaemia Care

The objective of this meeting, which brings together eminent haemoglobinopathies specialists and expert patient advocates from Italy and other countries, is to highlight the pivotal value of advocacy in enabling…
INTERNATIONAL THALASSAEMIA DAY 2022: Be Aware. Share. Care
TIF News (AR)

INTERNATIONAL THALASSAEMIA DAY 2022: Be Aware. Share. Care

Visit the International Thalassaemia Day (ITD) 2022 page, now LIVE on the TIF website, to discover the idea behind the ”Be Aware. Share. Care.” theme, our fantastic campaign resources, the…
RARE DISEASE DAY 2022 | Raising Awareness For People With Rare Diseases
أخبار

RARE DISEASE DAY 2022 | Raising Awareness For People With Rare Diseases

Rare Disease Day is the movement on rare diseases, working towards equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease everywhere…
What’s New In Clinical Trials For Thalassaemia/Sickle Cell Disease Drugs And Therapies?
Clinical News

What’s New In Clinical Trials For Thalassaemia/Sickle Cell Disease Drugs And Therapies?

Many pharmaceutical companies are making remarkable progress in their research into candidate treatments for these diseases and 2022 is expected to be yet another eventful year for haemoglobin disorders! Check…
THALIA 2018-2021: Europe Is Seeing A Surge In Thalassaemia, Project Results Show
TIF News (AR)

THALIA 2018-2021: Europe Is Seeing A Surge In Thalassaemia, Project Results Show

“Although thalassemia has always been endemic in Europe, especially in southern European countries such as Cyprus, Greece and Italy, the disease now knows no borders and constitutes an increasing health,…
TIF Article: COVID-19 Pandemic Exacerbated Existing Problems With Thalassaemia Care
TIF News (AR)

TIF Article: COVID-19 Pandemic Exacerbated Existing Problems With Thalassaemia Care

The article discusses how the COVID-19 pandemic has magnified challenges in thalassaemia care worldwide and underscores TIF’s activities throughout the coronavirus outbreak in support of patients with haemoglobinopathies. Hematology Advisor…
TIF Signs Agreement With Resonance Health To Deploy FerriSmart®
TIF News (AR)

TIF Signs Agreement With Resonance Health To Deploy FerriSmart®

FerriSmart is an AI-driven system for automated real-time measurement of liver-iron concentrate (LIC) in patients, using non-invasive MRI-based technology. Under the Letter of Agreement, TIF will engage with National Thalassaemia…
زر الذهاب إلى الأعلى